Top Abstract Purchase Related
Home
>
Node
>
Subnode

Determination of copper in liver puncture samples in the diagnosis of Wilson's disease

Wawschinek, O.; Beyer, W.

Journal of Clinical Chemistry and Clinical Biochemistry 20(12): 929-930

1982

ISSN/ISBN: 0340-076X
PMID: 7182431
Document Number: 195156
Wilson's disease, a hereditary disorder of copper metabolism, is characterized by excessive storage of this metal in several organs. Storage of copper in liver tissue is of great importance in diagnosis and therapy. By means of the combination of two methods - low-temperature ashing and flameless atomic absorption - the copper determination can be made even in smallest liver samples (needle-biopsy samples). It is therefore possible to perform a histological examination, as well as a quantitative copper determination on one puncture sample.

Document emailed within 1 workday
Secure & encrypted payments

Odièvre, M.; Benard, J.M.; Debray, H.; Neveu, Y.; Leleu, C.; Yvart, J.; Labrune, P.; Archambaud, F.; Bedossa, P.; Le Stradic, C. 1988: Wilson's disease with liver copper in normal concentration Archives Francaises de Pediatrie 45(8): 565-567
Diaz, J.; Acosta, F.; Cañizares, F.; Bueno, F.S.; Tornel, P.L.; Tovar, I.; Contreras, R.F.; Marquez, M.; Martinez, P.; Parrilla, P. 1995: Does orthotopic liver transplantation normalize copper metabolism in patients with Wilson's disease? Transplantation Proceedings 27(4): 2306
Marecek, Z.; Heyrovský, A.; Volek, V. 1975: The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease Acta Hepato-Gastroenterologica 22(5): 292-296
Lee, D.Y.; Brewer, G.J.; Wang, Y.X. 1989: Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model Journal of Laboratory and Clinical Medicine 114(6): 639-645
Kobayashi, S.; Ochiai, T.; Hori, S.; Suzuki, T.; Shimizu, T.; Gunji, Y.; Shimada, H.; Yamamoto, S.; Ogawa, A.; Kohno, Y.; Sunaga, M.; Shimazu, M.; Tanaka, K. 2001: Copper metabolism after living donor liver transplantation for hepatic failure of Wilson's disease from a gene mutated donor Hepato-Gastroenterology 48(41): 1259-1261
McQuaid, A.; Lamand, M.; Mason, J. 1992: The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy Journal of Laboratory and Clinical Medicine 119(6): 744-750
Degli Esposti, A.; Antener, I.; Ambrosioni, G.; Bonfiglioli, G. 1976: Wilson's disease. Summary of studies carried out in a family group with Wilson's disease. Significance of amino-acid balance in homo and heterozygotes for the detection of liver damage Minerva Pediatrica 28(34): 2063-2086
Stapelbroek, J.M.; Ploos van Amstel, J.K.; van Hattum, J.; van den Berg, L.H.; Klomp, L.W.J.; Houwen, R.H.J. 2003: From gene to disease; Wilson disease: copper storage due to mutations in ATP7B Nederlands Tijdschrift Voor Geneeskunde 147(13): 603-605
Guérin, J.M.; Raux, M.; Meresse, S.; Lamotte, M. 1982: Peritoneal dialysis for eliminating copper in patients with Wilson's disease La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(10): 613-615
Tempini, G.; Franco, G.; Broglia, L. 1983: Determination of magnesium, copper and zinc in biological samples using plasma emission spectrophotometry Giornale Italiano di Medicina del Lavoro 5(6): 263-265
Lee, H.H.; Hill, G.M.; Sikha, V.K.; Brewer, G.J.; Prasad, A.S.; Owyang, C. 1990: Pancreaticobiliary secretion of zinc and copper in normal persons and patients with Wilson's disease Journal of Laboratory and Clinical Medicine 116(3): 283-288
Pawlak, J. 1975: Copper metabolism disorders as an attempt at explaining analogous pathological mechanisms in Wilson's syndrome and severe cases of liver cirrhosis Wiadomosci Lekarskie 28(12): 1041-1044
Suzuki, K.T. 1995: Disordered copper metabolism in LEC rats, an animal model of Wilson disease: roles of metallothionein Research Communications in Molecular Pathology and Pharmacology 89(2): 221-240
Seidel, J.; Caca, K.; Schwab, S.G.; Berr, F.; Wildenauer, D.B.; Mentzel, H.J.; Horn, N.; Kauf, E. 2001: Disturbed copper transport in humans. Part 2: mutations of the ATP7B gene lead to Wilson disease (WD) Cellular and Molecular Biology 47 Online Pub: Ol149-Ol157
Leonhardt, W.; Niese, S.; Jarobb, W.; Hanefeld, M.; Schentke, K.U.; Renger, F. 1973: Activation analysis of human tissue samples: manganese, copper, and zinc in the liver Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 33(1): 17-24
Kok, K.F.; Hoevenaars, B.; Waanders, E.; Drenth, J.P.H. 2008: Value of molecular analysis of Wilson's disease in the absence of tissue copper deposits: a novel ATP7B mutation in an adult patient Netherlands Journal of Medicine 66(8): 348-350
Yuzbasiyan-Gurkan, V.; Brewer, G.J.; Abrams, G.D.; Main, B.; Giacherio, D. 1989: Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease Journal of Laboratory and Clinical Medicine 114(5): 520-526
Dastych, M. 1999: Serum levels of zinc, copper and selenium in patients with Wilson's disease treated with zinc Vnitrni Lekarstvi 45(4): 217-219
Valmary, J.; Ricordel, I.; Mazière, B.; Vergeau, B.; Fléchaire, A.; Algayres, J.P.; Daly, J.P.; Laverdant, C. 1988: Liver pathology in Wilson's disease Annales de Gastroenterologie et d'Hepatologie 24(4): 197-203
Kuntz, H.D.; May, B.; Ulmer, W.T. 1979: Wilson's disease or liver cirrhosis of a different etiology Münchener Medizinische Wochenschrift 121(46): 50